WO2004094651A3 - Novel human polypeptides encoded by polynucleotides - Google Patents

Novel human polypeptides encoded by polynucleotides Download PDF

Info

Publication number
WO2004094651A3
WO2004094651A3 PCT/US2004/012049 US2004012049W WO2004094651A3 WO 2004094651 A3 WO2004094651 A3 WO 2004094651A3 US 2004012049 W US2004012049 W US 2004012049W WO 2004094651 A3 WO2004094651 A3 WO 2004094651A3
Authority
WO
WIPO (PCT)
Prior art keywords
polynucleotides
polypeptides encoded
novel human
human polypeptides
modulators
Prior art date
Application number
PCT/US2004/012049
Other languages
French (fr)
Other versions
WO2004094651A2 (en
Inventor
Ernestine Lee
Kevin Hestir
Keting Chu
Mamoru Kamiya
Yoshihide Hayashizaki
Lorianne Masuoka
Lewis Thomas Williams
Original Assignee
Five Prime Therapeutics Inc
Ernestine Lee
Kevin Hestir
Keting Chu
Mamoru Kamiya
Yoshihide Hayashizaki
Lorianne Masuoka
Lewis Thomas Williams
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Five Prime Therapeutics Inc, Ernestine Lee, Kevin Hestir, Keting Chu, Mamoru Kamiya, Yoshihide Hayashizaki, Lorianne Masuoka, Lewis Thomas Williams filed Critical Five Prime Therapeutics Inc
Publication of WO2004094651A2 publication Critical patent/WO2004094651A2/en
Publication of WO2004094651A3 publication Critical patent/WO2004094651A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention provides novel polynucleotides, related polypeptides, related nucleic acid and polypeptide compositions, and related modulators, such as antibodies and small molecule modulators. The compositions of the invention are useful for diagnosis, prophylaxis, and treatment of proliferative, inflammatory, immune, infectious, metabolic, central nervous system, and bone cartilage disorders.
PCT/US2004/012049 2003-04-18 2004-04-19 Novel human polypeptides encoded by polynucleotides WO2004094651A2 (en)

Applications Claiming Priority (20)

Application Number Priority Date Filing Date Title
US46370003P 2003-04-18 2003-04-18
US60/463,700 2003-04-18
US46720303P 2003-05-02 2003-05-02
US60/467,203 2003-05-02
US47660903P 2003-06-09 2003-06-09
US47663203P 2003-06-09 2003-06-09
US60/476,609 2003-06-09
US60/476,632 2003-06-09
US48532503P 2003-07-08 2003-07-08
US48535903P 2003-07-08 2003-07-08
US60/485,325 2003-07-08
US60/485,359 2003-07-08
US48696003P 2003-07-15 2003-07-15
US60/486,960 2003-07-15
US49333203P 2003-08-08 2003-08-08
US49337003P 2003-08-08 2003-08-08
US60/493,332 2003-08-08
US60/493,370 2003-08-08
US50505903P 2003-09-08 2003-09-08
US60/505,059 2003-09-24

Publications (2)

Publication Number Publication Date
WO2004094651A2 WO2004094651A2 (en) 2004-11-04
WO2004094651A3 true WO2004094651A3 (en) 2009-03-26

Family

ID=33314651

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/012049 WO2004094651A2 (en) 2003-04-18 2004-04-19 Novel human polypeptides encoded by polynucleotides

Country Status (1)

Country Link
WO (1) WO2004094651A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2649250A1 (en) 2006-04-11 2007-10-25 Eisai R & D Management Co., Ltd. Dopaminergic neuron progenitor cell marker 187a5
US20100196351A1 (en) * 2007-02-15 2010-08-05 Geneswitch Innovations Llc Secreted pate-like proteins
WO2008141230A1 (en) * 2007-05-09 2008-11-20 Lawrence Livermore National Security, Llc Methods and systems for monitoring production of a target protein in a nanolipoprotein particle
US9688718B2 (en) 2008-01-11 2017-06-27 Lawrence Livermore National Security, Llc Nanolipoprotein particles comprising hydrogenases and related products, methods and systems
US9303273B2 (en) 2008-05-09 2016-04-05 Lawrence Livermore National Security, Llc Nanolipoprotein particles comprising a natural rubber biosynthetic enzyme complex and related products, methods and systems
WO2009143280A2 (en) 2008-05-22 2009-11-26 Lawrence Livermore National Security, Llc Nanolipoprotein particles and related compositions, methods and systems
US9453840B2 (en) 2011-07-27 2016-09-27 Kyoto University Markers for dopaminergic neuron progenitor cells
US9644038B2 (en) 2011-12-21 2017-05-09 The Regents Of The University Of California Apolipoprotein nanodiscs with telodendrimer
WO2016049061A1 (en) 2014-09-22 2016-03-31 Lawrence Livermore National Security, Llc Electrochemical flow-cell for hydrogen production and nicotinamide co-factor dependent target reduction, and related methods and systems
US11279749B2 (en) 2015-09-11 2022-03-22 Lawrence Livermore National Security, Llc Synthetic apolipoproteins, and related compositions methods and systems for nanolipoprotein particles formation
US11207422B2 (en) 2017-05-02 2021-12-28 Lawrence Livermore National Security, Llc MOMP telonanoparticles, and related compositions, methods and systems

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075067A2 (en) * 2000-03-31 2001-10-11 Hyseq, Inc. Novel nucleic acids and polypeptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075067A2 (en) * 2000-03-31 2001-10-11 Hyseq, Inc. Novel nucleic acids and polypeptides
US20050196754A1 (en) * 2000-03-31 2005-09-08 Drmanac Radoje T. Novel nucleic acids and polypeptides

Also Published As

Publication number Publication date
WO2004094651A2 (en) 2004-11-04

Similar Documents

Publication Publication Date Title
WO2004020595A8 (en) Novel human polypeptides encoded by polynucleotides
WO2004035732A3 (en) Human polypeptides encoded by polynucleotides and methods of their use
WO2004093804A3 (en) Human polypeptides encoded by polynucleotides and methods of their use
PL1767546T3 (en) Angiogenesis-inhibiting chimeric protein and the use
WO2008054561A3 (en) Proteins, nucleic acids encoding the same and associated methods of use
WO2002055705A3 (en) Proteins and nucleic acids encoding same
WO2002050277A3 (en) Protein and nucleic acids encoding same
WO2007060213A3 (en) Erythropoietin polypeptides and uses thereof
WO2004094651A3 (en) Novel human polypeptides encoded by polynucleotides
WO2007087053A3 (en) Bmp-7 variant compositions, methods and uses
WO2002068649A3 (en) Proteins and nucleic acids encoding same
WO2002081518A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2001090155A3 (en) Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
WO2008060776A3 (en) Atap peptides, nucleic acids encoding the same and associated methods of use
WO2004015060A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2005085280A3 (en) HUMAN cDNA CLONES COMPRISING POLYNUCLEOTIDES ENCODING POLYPEPTIDES AND METHODS OF THEIR USE
WO2001081578A3 (en) Novel proteins and nucleic acids encoding same
WO2002068652A3 (en) Nov-x proteins and nucleic acids encoding same
WO2002016599A3 (en) Proteins and nucleic acids encoding same
WO2002055704A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2002081510A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2004020591A3 (en) Methods of use for novel human polypeptides encoded by polynucleotides
WO2002079398A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002099116A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2004038003A3 (en) Human polypeptides encoded by polynucleotides and methods of their use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase